ArticleCureus2026

Exceptional and Durable Complete Response to Ado-Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer: A Case Report.

Yuko Tashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.